Therapeutic Targets in African-American Youth With Type 2 Diabetes

Trial Profile

Therapeutic Targets in African-American Youth With Type 2 Diabetes

Recruiting
Phase of Trial: Phase I

Latest Information Update: 25 Jul 2017

At a glance

  • Drugs Liraglutide (Primary) ; Metformin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Apr 2017 Status changed from not yet recruiting to recruiting.
    • 20 Jan 2017 Planned initiation date changed from 1 Nov 2016 to 7 Nov 2016.
    • 15 Nov 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top